Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zainab Abdurrahman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 10, 2019
Vaccine allergyDerek K Chu, Zainab Abdurrahman
Pediatric Transplantation|April 14, 2007
Sirolimus is not always responsible for new-onset proteinuria after conversion for chronic allograft nephropathyZainab Abdurrahman, Minnie Sarwal, Maria Millan, et al.
HIV Clinical Trials|October 30, 2003
Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapyMona Loutfy, Janet Raboud, Courtney Thompson, et al.
The Journal of Pediatrics|August 10, 2022
Revaccination and Adverse Event Recurrence in Patients with Adverse Events following ImmunizationCaroline E Muñoz, Beth MacDonald, Anne Pham-Huy, et al.
Vaccine|June 23, 2024
Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network studyTiffany Fitzpatrick, Peter Yamoah, Gina Lacuesta, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 10, 2019
Vaccine allergyDerek K Chu, Zainab Abdurrahman
Pediatric Transplantation|April 14, 2007
Sirolimus is not always responsible for new-onset proteinuria after conversion for chronic allograft nephropathyZainab Abdurrahman, Minnie Sarwal, Maria Millan, et al.
HIV Clinical Trials|October 30, 2003
Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapyMona Loutfy, Janet Raboud, Courtney Thompson, et al.
The Journal of Pediatrics|August 10, 2022
Revaccination and Adverse Event Recurrence in Patients with Adverse Events following ImmunizationCaroline E Muñoz, Beth MacDonald, Anne Pham-Huy, et al.
Vaccine|June 23, 2024
Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network studyTiffany Fitzpatrick, Peter Yamoah, Gina Lacuesta, et al.
Pageof 1